logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9416139 B1

PDFFull Text
Date of Patent:
Aug. 16, 2016

Filed:

Nov. 28, 2013

Spiro ring compound as hepatitis c virus (hcv) inhibitor and uses thereof

Applicant:

Sunshine Lake Pharma Co., Ltd., Dongguan, Guangdong, CN;

Inventors:

Jiancun Zhang, San Mateo, CA (US);

Yingjun Zhang, Dongguan, CN;

Hongming Xie, Dongguan, CN;

Qingyun Ren, Dongguan, CN;

Bailin Hu, Dongguan, CN;

Changping Fu, Dongguan, CN;

Xiwei Wu, Dongguan, CN;

Shifeng Li, Dongguan, CN;

Chenglin Wang, Dongguan, CN;

Zhikeng Zhang, Dongguan, CN;

Assignee:

SUNSHINE LAKE PHARMA CO., LTD., Dongguan, Guangdong, CN;

Attorneys:

Kam W. Law

Squire Patton Boggs (US) LLP

Primary Examiner:

Paul V Ward

Int. Cl.
CPC ...
C07D 491/113 (2006.01); C07D 401/14 (2006.01); C07D 405/14 (2006.01); C07D 413/14 (2006.01); A61K 31/423 (2006.01); A61K 31/435 (2006.01); A61K 31/4709 (2006.01); A61K 31/517 (2006.01); A61K 31/527 (2006.01); A61K 31/549 (2006.01); C07D 403/14 (2006.01); C07D 409/14 (2006.01); C07D 417/14 (2006.01); C07D 491/107 (2006.01); A61K 38/21 (2006.01); A61K 45/06 (2006.01); A61K 31/4184 (2006.01); A61K 38/20 (2006.01);
U.S. Cl.
CPC ...
C07D 491/113 (2013.01); A61K 31/4184 (2013.01); A61K 31/423 (2013.01); A61K 31/435 (2013.01); A61K 31/4709 (2013.01); A61K 31/517 (2013.01); A61K 31/527 (2013.01); A61K 31/549 (2013.01); A61K 38/204 (2013.01); A61K 38/208 (2013.01); A61K 38/2013 (2013.01); A61K 38/21 (2013.01); A61K 45/06 (2013.01); C07D 401/14 (2013.01); C07D 403/14 (2013.01); C07D 405/14 (2013.01); C07D 409/14 (2013.01); C07D 413/14 (2013.01); C07D 417/14 (2013.01); C07D 491/107 (2013.01);
Abstract

A compound of formula (I) or a stereoisomer, a geometric isomer. a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof is provided, which can be used for treating HCV infection or a HCV disorder. Also a pharmaceutical composition comprising the compound and the use of the compound and the pharmaceutical composition thereof are provided, which can also be used for treating HCV infection or a HCV disorder.

Find Patent Forward Citations

Loading…